KAPPAMAB FOR RELAPSED REFRACTORY MULTIPLE MYELOMA (PHASE IIB)
AMaRC 16-01
ITD FOR RELAPSED REFRACTORY MULTIPLE MYELOMA (PHASE II)
AMaRC 16-02
VCD-D FOR TRANSPLANT INELIGIBLE MYELOMA (Phase II)
AMaRC 17-01
V-VCD FOR TRANSPLANT ELIGIBLE MYELOMA (PHASE II)
AMaRC 18-01
IRIL FOR TRANSPLANT INELIGIBLE MYELOMA (PHASE II)
AMaRC 18-02
FRAIL-M FOR TRANSPLANT INELIGIBLE MYELOMA (PHASE I/II)
AMaRC 19-01
BELANTAMAB for relapsed refractory multiple myeloma
AMaRC 19-02